Family · Pharmaceutical analytical standards
Remifentanil
An ultra-short-acting synthetic opioid used in general anaesthesia, for pain relief during surgery and for sedation in intensive care; approved in the United States in 1996. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?It has an ester bond that esterases in blood and tissues break down rapidly: even after a four-hour infusion, its concentration halves in about four minutes.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
